(Q39503916)

12 September 2017

title

Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells (English)

1 reference

12 September 2017

1 reference

Takashi Otsuka

1

1 reference

12 September 2017

Kazuhiro Iguchi

2

1 reference

12 September 2017

Kazuhiro Fukami

3

1 reference

12 September 2017

Kenichiro Ishii

4

1 reference

12 September 2017

Shigeyuki Usui

5

1 reference

12 September 2017

Yoshiki Sugimura

6

1 reference

12 September 2017

Kazuyuki Hirano

7

1 reference

12 September 2017

publication date

20 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

32

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

1097-1102

1 reference

New strategies for the medical treatment of prostate cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Androgen receptor involvement in the progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Isolation and characterization of LNCaP sublines differing in hormone sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Mitogen-activated protein kinase pathway is involved in alpha6 integrin gene expression in androgen-independent prostate cancer cells: role of proximal Sp1 consensus sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Degradation and beyond: control of androgen receptor activity by the proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0209-Y

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

21 January 2018

1 reference

12 December 2020

Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors

1 reference

12 December 2020

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy

1 reference

12 December 2020

Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10.

1 reference

12 December 2020

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

1 reference

12 December 2020

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

1 reference

12 December 2020

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer

1 reference

12 December 2020

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers

1 reference

12 December 2020

Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells

1 reference

12 December 2020

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

1 reference

12 December 2020

10.1007/S13277-011-0209-Y

Identifiers

DOI

1 reference

12 September 2017

1 reference